TOP STORIES

• REGULATORY Pharma Support Needed to Bridge Biotech’s “Valley of Death”: Council Member
  September 26, 2025

• BUSINESS Nippon Zoki Shooting for 50% Overseas Sales by FY2035
  September 25, 2025

• BUSINESS Mochida and Itochu to Each Take 20% Stake in And Pharma
  September 24, 2025

• REGULATORY FPMAJ Calls for Scrapping Huge-Seller, Spillover Re-Pricing at Public-Private WG Hearing
  September 24, 2025

• REGULATORY Japan Approves Pluvicto, Izervay, and Lots More; Subcutaneous Rybrevant Not on Roster
  September 22, 2025

• ORGANIZATION JPMA Sets Up Multilateral Advocacy Group to Bolster Global Voice: International Affairs Chair
  September 19, 2025

• REGULATORY FPMAJ Urges Blanket Drug Price Hikes to Offset Inflation: FY2026 Reform Talks
  September 18, 2025

• REGULATORY J&J’s Subcutaneous Rybrevant Faces Delay in Japan Approval Process
  September 17, 2025

• BUSINESS Alnylam Sees Japan Business Doubling as Amvuttra Expands into ATTR-CM
  September 17, 2025

• BUSINESS Predictability Key to Novartis’ Japan Investment, Says International Chief
  September 16, 2025

• BUSINESS LEO Pharma Reinforces Japan Push toward Dermatology Leadership
  September 12, 2025

• BUSINESS Sawai and T’s Pharma Won Forxiga Generics by Skirting Patent, Will the Strategy Hold?
  September 11, 2025

• REGULATORY Reblozyl Faces Price Cut after Cost-Effectiveness Assessment
  September 11, 2025

• BUSINESS Teijin Pharma Bets on Ascendis Rare Disease Assets as Feburic Sales Crumble
  September 10, 2025

• BUSINESS Amicus CEO Confident on US$1 Billion Sales Target as Japan Pompe Launch Gets Underway
  September 9, 2025

• BUSINESS KM Biologics Developing Higher-Yield Liquid Immunoglobulin to Boost Efficiency and Supply
  September 8, 2025

• ORGANIZATION JPMA Code & Compliance Chair Stresses Need to Embed Spirit of Revised COP
  September 8, 2025

• COMMENTARY MHLW Grows Jittery over Supply Risks amid Rising Foreign Investments
  September 8, 2025

• BUSINESS And Pharma Chief Pledges Growth Strategy as New Generics Holding Firm Takes Shape
  September 5, 2025

• ORGANIZATION JPMA ICH Project Chair Sees RWE as Potential Complement to Clinical Trials
  September 5, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• …
• Next ›
• 最終 »